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Abstract (Word Count 200) 27 
 28 
Background 29 
Resistance to major public health insecticides in Côte d’Ivoire has intensified and now threatens 30 
the long-term effectiveness of malaria vector control interventions.  31 
 32 
Methods 33 
This study evaluated the bioefficacy of conventional and next-generation long-lasting 34 
insecticidal nets (LLINs), determined resistance profiles, and characterized molecular and 35 
metabolic mechanisms in wild Anopheles coluzzii from South-East Côte d’Ivoire in 2019. 36 
 37 
Results 38 
Phenotypic resistance was intense: more than 25% of mosquitoes survived exposure to ten 39 
times the doses of pyrethroids required to kill susceptible populations. Similarly, 24-hour 40 
mortality to deltamethrin-only LLINs was very low and not significantly different to an untreated 41 
net. Sub-lethal pyrethroid exposure did not induce significant delayed vector mortality 72 hours 42 
later. In contrast, LLINs containing the synergist piperonyl butoxide (PBO), or new insecticides, 43 
clothianidin and chlorfenapyr, were highly toxic to An. coluzzii. Pyrethroid-susceptible An. 44 
coluzzii were significantly more likely to be infected with malaria, compared to those that 45 
survived insecticidal exposure. Pyrethroid resistance was associated with significant over-46 
expression of CYP6P4, CPY6Z1 and CYP6P3. 47 
 48 
Conclusions 49 
Study findings raise concerns regarding the operational failure of standard LLINs and support 50 
the urgent deployment of vector control interventions incorporating PBO, chlorfenapyr or 51 
clothianidin in areas of high resistance intensity in Côte d'Ivoire. 52 
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 57 
Introduction  58 
 59 
In Côte d’Ivoire, malaria is a serious public health problem with the entire population of ~26.2 60 
million people is at risk, and disease prevalence reaching as high as 63% in the south-west 61 
region [1]. Control of Anopheles gambiae s.l., the major malaria vector species group in Côte 62 
d’Ivoire, has been through the efforts of the National Malaria Control Programme (NMCP), 63 
which has distributed insecticide-treated nets (ITNs) as the primary vector control intervention. 64 
Indoor residual spraying (IRS) and larviciding in high transmission areas have been 65 
recommended as complementary strategies; implementation of the former has commenced in 66 
late 2020 [2]. Estimates of net coverage across the country remain low, with the proportion of 67 
households with at least one ITN for every two people rising from 31% in 2012 to 47% in 2016, 68 
and ITN use stagnating at 40% of households reporting sleeping under a net the previous night 69 
in both survey years [2]. The most recent universal net campaigns in Côte d’Ivoire in 2017–2018 70 
issued conventional, pyrethroid (deltamethrin) long-lasting insecticidal nets (LLINs), aiming to 71 
achieve 90% coverage and 80% use [2]. However, country-wide, multi-class insecticide 72 
resistance among populations of An. gambiae s.l. is a growing cause for concern because of 73 
potential operational failure of current vector control strategies, both locally, as well as across 74 
the sub-Saharan region [2,3]. 75 
Resistance to pyrethroid and carbamate insecticides in Anopheles mosquitoes was first 76 
reported from the central region of Côte d’Ivoire in the early 1990s [4-7]. Subsequently, local 77 
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resistance to the major insecticide classes recommended by the World Health Organization 78 
(WHO) for adult mosquito control – pyrethroids, carbamates, organophosphates, and 79 
organochlorines – evolved rapidly [8–10] and has been increasing in intensity, driven largely by 80 
selective pressures imposed by contemporaneous scale-up of public health vector control 81 
interventions (including those targeting malaria, trypanosomiasis and onchocerciasis vectors) 82 
and use of agricultural pesticides [7, 11–14]. This escalation in resistance has now begun to 83 
compromise the insecticidal efficacy and community-wide impact of conventional, pyrethroid 84 
LLINs in Côte d’Ivoire [14,15], although some levels of personal protection may still remain [15–85 
17]. 86 
Amongst vector populations across Côte d’Ivoire, the L1014F kdr mutation is pervasive and has 87 
been implicated in some longitudinal trends in decreasing DDT and pyrethroid susceptibility [7, 88 
11]; L1014S kdr and N1575Y resistance mutations have also been detected but at much lower 89 
frequencies [18]. Extreme carbamate (bendiocarb) resistance and pyrethroid cross-resistance in 90 
local An. gambiae s.s. populations have been shown to be mediated by over-expression of 91 
CYP6P3 and CYP6M2 and duplication of the G119S Ace-1 mutation [19]. 92 
To support and safeguard future malaria control efforts in Côte d’Ivoire, this study evaluated the 93 
efficacy of conventional and next-generation LLINs for prospective distribution; determined 94 
current insecticide resistance profiles of An. gambiae s.l. (principally An. coluzzii); and 95 
characterized underlying molecular and metabolic resistance mechanisms.  96 
 97 
 98 
 99 
 100 
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Methods 101 
Study area and mosquito collections 102 
 103 
The study protocol was approved by the Comité National d’Ethique des Sciences de la Vie et de 104 
la Santé (#069-19/MSHP/CNESVS-kp) and the London School of Hygiene and Tropical 105 
Medicine (#16782 and #16899). Study activities were conducted in the village of Aboudé, rural 106 
Agboville, Agnéby-Tiassa region, south-east Côte d'Ivoire (5°55’N and 4°13’W), selected due to 107 
its high mosquito densities and malaria prevalence (26% in children <5 years old, in recent 108 
estimates [1]). Adult mosquitoes were collected nightly between 5th July and 26th July 2019, 109 
using human landing catches (HLCs), inside and outside households from 18:00 to 06:00hr. 110 
Unfed mosquitoes, morphologically identified as An. gambiae s.l. [20], were tested in bioassays 111 
that same day, following a brief recovery period; blood-fed mosquitoes were first held for 2–3 112 
days to allow for blood-meal digestion. 113 
  114 
WHO cone bioassay testing 115 
 116 
Two types of LLIN were evaluated in this study. PermaNet® 2.0 is a conventional LLIN treated 117 
with deltamethrin only (1.4g/kg±25%) and PermaNet® 3.0 is a PBO synergist LLIN, consisting of 118 
a roof containing PBO (25g/kg) and deltamethrin (4g/kg±25%) and side panels containing 119 
deltamethrin only (2.8g/kg±25%). WHO cone bioassays were used to test the susceptibility of 120 
An. gambiae s.l. exposed to unwashed PermaNet® 2.0, PermaNet® 3.0 roof panels and 121 
PermaNet® 3.0 side panels [21]. To control for potential variation in insecticide/synergist 122 
content, each of five LLINs per type was cut into 19 pieces, measuring 30 x 30cm, with each 123 
piece tested a maximum of three times.  124 
 125 
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Resistance intensity and synergist bioassay testing 126 
 127 
Centers for Disease Control and Prevention (CDC) resistance intensity bioassays were 128 
performed for six public health insecticides (pyrethroids: alpha-cypermethrin, deltamethrin and 129 
permethrin; carbamate: bendiocarb; neonicotinoid: clothianidin; and pyrrole; chlorfenapyr) 130 
[22,23]. The diagnostic doses of all insecticides were evaluated (including clothianidin: 131 
90µg/bottle [23] and chlorfenapyr: 100µg/bottle) and 2, 5 and 10 times the diagnostic dose of 132 
pyrethroid insecticides were also used. Per test, knock-down was recorded at 15-minute 133 
intervals for 30 minutes (pyrethroids and bendiocarb) or 60 minutes (clothianidin and 134 
chlorfenapyr) of insecticide exposure. PBO pre-exposures were performed using WHO tube 135 
assays [24], prior to CDC bottle bioassay testing.  136 
 137 
WHO cone and CDC resistance intensity bioassay data were interpreted according to the WHO 138 
criteria [21,22].  Mosquitoes which died following exposure to a LLIN or 1X insecticide dose 139 
were stored at -20°C in RNAlater® (Thermo Fisher Scientific, UK) and were considered 140 
‘susceptible’ for genotypic analysis. Surviving mosquitoes were held and scored for mortality 141 
after 24, 48 and 72 hours to observe delayed mortality. Kaplan-Meier curves were used to 142 
visualize survival data, and Cox regression was used to compare post-exposure survival. 143 
Immediate mortality following LLIN (60 minutes and 24 hours) or insecticidal exposure (30 or 60 144 
minutes, depending on insecticide) were excluded. Surviving mosquitoes at 72 hours were 145 
stored at -20°C in RNAlater® and were considered ‘resistant’ for genotypic analysis.  146 
 147 
 148 
 149 
 150 
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Mosquito processing, identification of Anopheles gambiae s.l. species complex members and 151 
Plasmodium falciparum detection 152 
 153 
A sub-sample of field-caught mosquitoes that were tested in bioassays were selected for 154 
molecular analysis (n=912). Approximately equal numbers of specimens were chosen to 155 
represent phenotypically ‘susceptible’ or ‘resistant’ mosquitoes for each LLIN type or insecticide 156 
dose, and selected across different replicates/testing days to capture as much population-level 157 
variation as possible. RNA was extracted from individual whole-body mosquitoes according to 158 
standard protocols [23]. Field An. gambiae s.l. were identified to species-level by amplification of 159 
the SINE200 insertion that differentiates An. coluzzii and An. gambiae s.s. [25] and were 160 
screened for the presence of Plasmodium falciparum [26]. 161 
 162 
Characterization of insecticide resistance mechanisms: target site mutations  163 
The same cohort of field mosquitoes (n=912) were tested for the presence of the L1014F kdr 164 
[27] and N1575Y mutations [28]. A sub-sample of mosquitoes (n=49) which were exposed to 165 
bendiocarb, clothianidin or chlorfenapyr were tested for the presence of the G119S Ace-1 166 
mutation [29]. Pearson’s Chi-squared tests and Fisher’s exact tests (when sample sizes were 167 
small) were used to investigate the statistical association between resistance status, allele 168 
frequencies and deviations from Hardy-Weinberg equilibrium. 169 
 170 
 171 
 172 
 173 
 174 
 175 
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Characterization of insecticide resistance mechanisms: metabolic gene expression 176 
 177 
Relative expression of five metabolic genes (CYP6P3, CYP6P4, CYP6Z1 CYP6P1 and GSTE2) 178 
was measured in all field collected mosquitoes (n=912), using multiplex quantitative real-time 179 
PCR (qRT-PCR) assays, relative to the housekeeping gene ribosomal protein S7 (RPS7) [30]. 180 
In addition, gene expression levels were measured in susceptible An. coluzzii N’gousso colony 181 
mosquitoes (n=48). All samples were run in technical triplicate. Relative expression level and 182 
Fold Change (FC) of each target gene from resistant and susceptible field samples, relative to 183 
the susceptible laboratory strain, were calculated using the 2-ΔΔCT method incorporating PCR 184 
efficiency, normalised relative to the endogenous control gene (RPS7). 185 
 186 
Results 187 
 188 
Mosquito collections and species identification 189 
 190 
A total of 4,609 female An. gambiae s.l. mosquitoes were collected in Agboville, Côte d'Ivoire. 191 
Of those, 912, which were previously tested in either LLIN bioefficacy assays (n=384) or 192 
resistance intensity bioassays (n=528), were selected for molecular species identification, with 193 
805 (88.3%) determined to be An. coluzzii, 75 (8.2%) An. gambiae s.s. and 22 (2.4%) An. 194 
gambiae-An. coluzzii hybrids; 10 individuals did not amplify.  195 
 196 
Long-lasting insecticidal net efficacy 197 
 198 
A total of 2,666 field-caught An. gambiae s.l. were used to assess the bioefficacy of 199 
conventional pyrethroid-treated LLINs (PermaNet® 2.0 and PermaNet® 3.0 side panels) and 200 
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next-generation synergist LLINs (PermaNet® 3.0 roof panels), compared to an untreated control 201 
(Figure 1).  202 
 203 
Overall, levels of An. gambiae s.l. knock-down and mortality to deltamethrin LLINs, were very 204 
low and largely equivalent to the untreated control net (Figure 1). At 60 minutes, average 205 
mosquito knock-down to the untreated control, PermaNet® 2.0 and PermaNet® 3.0 side panels 206 
was 1.56% (95% CI: 1.13-1.99%), 0.54% (95% CI: 0.42-0.65%) and 1.75% (95% CI: 1.49-207 
2.0%), respectively. By contrast, average mosquito knock-down for PBO-containing PermaNet® 208 
3.0 roof panels was significantly higher (79.8%, 95% CI: 79.07-80.48%;  2 =705.51, 968.65 and 209 
937.33; p<0.001, versus untreated control, PermaNet® 2.0 and PermaNet® 3.0 side panels, 210 
respectively) (Figure 1).  211 
 212 
At 24 hours, mortality to the untreated control, PermaNet® 2.0 and PermaNet® 3.0 side panels 213 
remained low (6.11%, 95% CI: 4.71-7.51%; 5.44%, 95% CI: 4.58-6.29% and 3.66%, 95% CI: 214 
3.12-4.19%, respectively), while mortality to PermaNet® 3.0 roof panels increased only 215 
marginally but still remained significantly higher (83.81%, 95% CI: 83.15-84.47%;  2 =727.96, 216 
914.61 and 963.09; p<0.001 for all, versus untreated control, PermaNet® 2.0 and PermaNet® 217 
3.0 side panels, respectively) (Figure 1). PermaNet® 3.0 roof panels reached minimal 218 
effectiveness (knock-down ≥75%) 60 minutes after exposure and optimal effectiveness 219 
(mortality ≥80%) at 24 hours. Neither of the deltamethrin-only LLINs reached either 220 
effectiveness threshold at any time point.  221 
 222 
Insecticide resistance intensity 223 
 224 
One thousand, nine hundred and forty-three field-caught An. gambiae s.l. were tested in 225 
resistance bioassays. Intense pyrethroid resistance was evident with more than 25% of 226 
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mosquitoes surviving exposure to ten times the dose of insecticide required to kill a susceptible 227 
population; at the diagnostic dose, mosquito mortality did not exceed 25% for any pyrethroid 228 
tested (Figure 2A). These results are consistent with the high survival rates observed during 229 
cone bioassays using conventional LLINs (Figure 1). In general, levels of resistance to alpha-230 
cypermethrin, deltamethrin and permethrin were not significantly different at each insecticide 231 
concentration tested (Figure 2A).  232 
 233 
By comparison, carbamate tolerance was low, with mean knock-down of 94.53% (95% CI: 234 
92.11-96.95%) after 30 minutes exposure to the diagnostic dose of bendiocarb. Similarly, high 235 
levels of susceptibility to new insecticides clothianidin and chlorfenapyr were observed, with 236 
mean mortality of 94.11% (95% CI: 93.43-94.80%; n=102) and 95.54% (95% CI: 94.71-96.36%; 237 
n=112), respectively, 72 hours after exposure to the tentative diagnostic doses.  238 
 239 
Pre-exposure to PBO increased average An. gambiae s.l. mortality significantly from 14.56% 240 
(95% CI: 6.24-22.88%) to 72.73% (95% CI: 64.81-79.43) and from 44.66% (95% CI: 34.86-241 
54.46%) to 94.17% (95% CI: 91.12-97.22) after exposure to one or two times the diagnostic 242 
dose of deltamethrin (Figure 2B). 243 
 244 
Mosquito survival following insecticidal exposure 245 
 246 
All An. gambiae s.l. tested in LLIN bioefficacy or resistance intensity bioassays, were held for 72 247 
hours, to assess any impact of insecticide or net exposure on delayed mortality. For LLIN 248 
bioassays, there was little evidence for any reduction in survival during this holding period (Cox 249 
regression P= 0.149, 0.272 and 0.85 comparing PermaNet® 2.0, PermaNet® 3.0 side panels and 250 
PermaNet® 3.0 roof panels versus untreated control, respectively) (Table 1 and Figure 3A). 251 
Exposure to the diagnostic doses of all insecticides in CDC bottle bioassays did not induce 252 
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significant delayed mortality over 72 hours (Cox regression P>0.05 for all insecticides compared 253 
to the control; with the exception of chlorfenapyr, P=0.02) (Table 1 and Figure 3B). This 254 
phenomenon was also observed at increasing pyrethroid doses (Cox regression P>0.05 for 255 
alpha-cypermethrin, deltamethrin and permethrin 5X and 10X versus either the control or 256 
diagnostic dose) (Table 1; Figure 3C and 3D).  257 
 258 
Malaria prevalence 259 
 260 
Of the 912 An. gambiae s.l. mosquitoes assayed, 31 tested positive for P. falciparum (3.4%). 261 
For PCR-confirmed An. coluzzii, P. falciparum prevalence was 3.50% (28/805); the remaining 262 
three infections were in An. gambiae s.s. (4%; 3/75). By resistance phenotype, susceptible An. 263 
coluzzii (i.e. those which died following pyrethroid exposure) were more likely to be infected with 264 
malaria, compared to resistant mosquitoes (2 =4.6987; p=0.030); infection rates were 5.94% 265 
(13/219) and 2.49% (10/401), respectively. 266 
 267 
Target site resistance mutations 268 
 269 
L1014F kdr screening revealed 92.2% (796/863) of An. gambiae s.l. mosquitoes harboured the 270 
mutation; 71.5% (617/863) were homozygous, 20.7% (179/863) were heterozygous, 5.1% 271 
(44/863) were wild type and 2.6% (23/863) did not amplify. For PCR-confirmed An. coluzzii, 272 
L1014F kdr prevalence was 87.8% (707/805); 66.6% (536/805) were homozygous for the 273 
mutation, 21.2% (171/805) were heterozygous, 5.3% (43/805) were wild type and 2.2% (18/805) 274 
did not amplify. For An. coluzzii, population-level L1014F kdr allele frequency was 0.83, with 275 
evidence for significant deviations from Hardy-Weinberg equilibrium (2 =29.124; p<0.0001). 276 
There was no significant association between L1014F kdr frequency and ability of mosquitoes to 277 
survive pyrethroid exposure, in either LLIN or resistance bioassays (2 =2.0001; p=0.157 and 278 
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
2 
=3.7577; p=0.0.53, respectively). Similarly, there was no significant association between 279 
L1014F kdr and ability of mosquitoes to survive PBO pre-exposure and pyrethroid treatment, in 280 
either LLIN or resistance bioassays (2 =0.0086; p=0.926, Fisher’s exact=0.429, respectively). 281 
For PCR-confirmed An. gambiae s.s., L1014F kdr prevalence was 95.3% (61/64); 89.1% 282 
(57/64) were homozygous for the mutation, 6.3% (4/64) were heterozygous, none were wild 283 
type and 4.7% (3/64) did not amplify. For An. gambiae s.s., population-level L1014F kdr allele 284 
frequency was 0.97, with no significant deviations from Hardy-Weinberg equilibrium (2 =0.070; 285 
p=0.791). 286 
 287 
N1575Y screening revealed 2.3% (21/912) of An. gambiae s.l. mosquitoes harboured the 288 
mutation; all of these were heterozygotes. N1575Y prevalence was 1.1% (9/805) and 16% 289 
(12/75) for PCR-confirmed An. coluzzii and An. gambiae s.s., respectively; 0.99% (9/912) did 290 
not amplify. There was no evidence for ongoing N1575Y selection in either species (2 =0.026; 291 
p=0.873 and 2 =0.62; p=0.433 for An. coluzzii and An. gambiae s.s., respectively). For An. 292 
coluzzii, there was no significant association between N1575Y frequency and ability of 293 
mosquitoes to survive pyrethroid exposure, in LLIN or resistance bioassay (2 =0.0001; p=0.993 294 
and 2 =0.3244; p=0.569, respectively).  295 
 296 
G119S Ace-1 screening revealed 55.1% (27/49) of An. gambiae s.l. mosquitoes harboured the 297 
mutation; all of these were heterozygotes. G119S Ace-1 prevalence was 64.9% (24/37) and 298 
27.3% (3/11) for PCR-confirmed An. coluzzii and An. gambiae s.s., respectively; one remaining 299 
An. gambiae-An. coluzzii hybrid was wild type. For An. coluzzii, population-level G119S Ace-1 300 
allele frequency was 0.32, with evidence for significant deviations from Hardy-Weinberg 301 
equilibrium (2 =8.525; p=0.00350). For An. gambiae s.s., population-level G119S Ace-1 allele 302 
frequency was 0.14, with no significant deviations from Hardy-Weinberg equilibrium (2 =0.274; 303 
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p=0.6005). For An. coluzzii, there was a significant association between presence of the G119S 304 
Ace-1 mutation and surviving bendiocarb exposure (Fisher’s exact test = 0.005).  305 
 306 
Metabolic resistance mechanisms 307 
 308 
Comparison of metabolic gene expression levels in field populations of An. coluzzii and An. 309 
gambiae s.s. demonstrated significant upregulation of CYP6P4 (FC=5.88, 95% CI: 5.19-44.06; 310 
and 6.08, 95% CI: 5.43-50.64), CPY6Z1 (FC=4.04, 95% CI: 3.69-41.54; and 3.56, 95% CI: 3.24-311 
36.25) and CYP6P3 (FC=12.56, 95% CI: 11.40-123.83; and 13.85, 95% CI: 12.53-132.03), 312 
relative to a susceptible laboratory colony, respectively (Figure 4). More modest overexpression 313 
of CYP6P1 and GSTE2 was observed (FC=1.18, 95% CI: 1.08-12.31; and 1.28, 95% CI: 1.17-314 
14.40; FC=0.56, 95% CI: 0.48-3.32; and 0.67, 95% CI: 0.58-4.29; for An. coluzzii and An. 315 
gambiae s.s., respectively) (Figure 4). Levels of FC did not differ significantly between the two 316 
species for any gene nor by malaria infection status in wild An. coluzzii. 317 
 318 
Comparison of metabolic gene expression in phenotyped field populations of An. coluzzii  319 
revealed lower FCs overall, but notably, increased overexpression of CYP6P3 in survivors of 320 
bendiocarb, deltamethrin, PBO + deltamethrin and permethrin (FC = 3.91, 95% CI: 3.33-22.16; 321 
2.21, 95% CI: 1.88-12.53; 2.64, 95% CI: 2.21-13.69; and 2.21, 95% CI: 1.99-20.03, 322 
respectively) (Figure 5). 323 
 324 
 325 
 326 
 327 
 328 
 329 
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Discussion 330 
 331 
Côte d’Ivoire is a hot spot of some of the highest levels of resistance of Anopheles mosquitoes 332 
to public health insecticides worldwide, with potentially severe implications for sustaining gains 333 
in malaria control [31]. To safeguard future malaria vector control efforts and inform the design 334 
of effective resistance management strategies, involving tactical deployment of differing IRS and 335 
LLIN modalities, there needs to be a clear understanding of contemporary phenotypic and 336 
genotypic insecticide resistance. 337 
  338 
Our study detected intense pyrethroid resistance in south-east, Côte d’Ivoire, as evidenced by 339 
high proportions of survivors, following exposure to ten times the diagnostic doses of 340 
pyrethroids, as well as very low levels of knock-down and 24-hour mortality to deltamethrin-only 341 
LLINs, equivalent to an untreated net. These findings are largely in agreement with historical 342 
resistance profiles from this region [7,10,11] and indicate that conventional LLINs may no longer 343 
be operationally viable in areas of high pyrethroid resistance intensity. Previous Phase II studies 344 
of pyrethroid-only LLINs in the central region of Côte d’Ivoire have demonstrated similarly poor 345 
efficacy with highly resistant An. gambiae s.l. populations but argued for the retention of some 346 
degree of personal protection [15-17]. Other observational cohorts have reported higher 347 
incidences of malaria among non-net users compared to users in areas of moderate to high 348 
pyrethroid resistance [17]. The extent of protective efficacy afforded by pyrethroid LLINs will 349 
likely reflect the strength of local vector resistance and levels of both net physical integrity and 350 
individual compliance [32,33]. However, in Côte d’Ivoire, reported LLIN usage has been low, 351 
requiring additional behavioural interventions [2,34]. Our findings of high mosquito mortality 352 
following exposure to clothianidin and chlorfenapyr and improved vector susceptibility with PBO 353 
treatment (on both LLINs and in resistance bioassays), are consistent with data from other 354 
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sentinel sites across Côte d’Ivoire [16,35,36], and strongly support the deployment of vector 355 
control interventions incorporating these new active ingredients. 356 
  357 
Study results indicate that An. coluzzii was the predominant local vector species during the rainy 358 
season, as observed previously [7], circulating sympatrically with smaller proportions of An. 359 
gambiae s.s.. These two vector species commonly co-habit but can be genetically distinct in 360 
terms of resistance mechanisms [37,38] and can also differ in larval ecology, behaviour, 361 
migration and aestivation [39-41]. In general, resistance mechanisms in An. coluzzii are less 362 
well-characterized, compared to An. gambiae s.s., in part because these vectors are 363 
morphologically indistinguishable and few studies present data disaggregated by PCR-364 
confirmed species. We observed several distinct features in our study, principally, evidence for 365 
ongoing selection of L1014F kdr and G119S Ace-1 in An. coluzzii, which was absent in An. 366 
gambiae s.s. and higher proportions of N1575Y in An. gambiae s.s.; expression levels of 367 
metabolic genes were comparable between species. The lack of association between L1014F 368 
kdr genotype and mosquito phenotype, coupled with the identification of three CYP450 369 
enzymes (CYP6P4, CYP6P3 and CYP6Z1) that were significantly over-expressed in field 370 
populations, (some of which are known to metabolise pyrethroids and next generation LLIN 371 
insecticides [42,43]), indicate a key role for metabolic resistance in this An. coluzzii population. 372 
One notable difference in our dataset, compared to previous work in Agboville [7], was the 373 
finding of bendiocarb susceptibility. This may be attributable to small-scale spatial and 374 
longitudinal heterogeneity in resistance, which can be highly dynamic [37,44], and/or phenotypic 375 
differences between vector species.   376 
  377 
With the exception of chlorfenapyr, which is known to be a slow-acting insecticide, we did not 378 
detect any delayed mortality effects for 72 hours following insecticidal exposure; the format and 379 
dose used for clothianidin testing (another slow-acting insecticide [45]) was instead intended to 380 
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measure acute toxicity within a 60 minute exposure period. Previous mathematical models 381 
using resistant mosquito colonies have suggested that sub-lethal insecticide treatment may still 382 
reduce vector lifespan and inhibit blood-feeding and host-seeking behaviours, thereby 383 
interrupting malaria transmission [46,47]. Our observations are more compatible with reports 384 
from Burkina Faso where different exposure regimens of wild, resistant An. gambiae s.l. 385 
populations to deltamethrin LLINs did not induce any delayed mortality [47]. Further assessment 386 
of sublethal effects are warranted across additional field populations with differing resistance 387 
mechanisms to better understand the impact of insecticidal exposure on vectorial capacity of 388 
resistant mosquitoes.   389 
  390 
To date there is a paucity of data regarding the interactions between insecticide resistance and 391 
Plasmodium development [48]. In this study, An. coluzzii which died following pyrethroid 392 
exposure were significantly more likely to be infected with malaria. This might be explained by 393 
elevated metabolic enzymes and/or prior pyrethroid exposure detrimentally affecting parasite 394 
development [49]; although it is important to note that we did not detect any significant 395 
differences between gene overexpression in malaria infected vs. non-infected An. coluzzii. 396 
Alternatively, our sampled population may have been physiologically older, as phenotypic 397 
resistance is known to decline with age [50]. It is impossible to distinguish between these 398 
hypotheses using field-collected vector populations; the experimental design used in this study 399 
had other biological and technical limitations, which have been described in detail previously 400 
[23,37]. 401 
 402 
Conclusions 403 
 404 
As new combination and bi-treated vector control interventions become available for 405 
deployment, contemporary resistance information is crucial for the rationale design of 406 
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management strategies and to mitigate future selection for particular resistance mechanisms. 407 
The results from this study contribute to growing insecticide resistance data for Côte d’Ivoire, 408 
demonstrating a loss of bioefficacy of conventional pyrethroid LLINs and supporting the use of 409 
new active ingredients (clothianidin, chlorfenapyr and PBO). Study findings also highlight the 410 
need for expanded insecticide resistance surveillance, including monitoring of metabolic 411 
resistance mechanisms, in conjunction with studies to better characterize the impact of 412 
sublethal insecticide exposure on vectorial capacity and the interaction between insecticide 413 
resistance on Plasmodium parasite development.  414 
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 589 
Figures 590 
 591 
 592 
 593 
Figure 1. Bioefficacy of different unwashed LLINs against field-caught An. gambiae s.l. Mean 594 
knock-down and mortality rates with 95% confidence intervals (CI) at 60 minutes and 24 hours, 595 
respectively, after 3 minutes exposure to PermaNet® 2.0 (deltamethrin only), side panels of 596 
PermaNet® 3.0 (deltamethrin only), roof panels of PermaNet® 3.0 (PBO + deltamethrin) and an 597 
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untreated control net. Knock-down or mortality in the same time period for each treatment 598 
sharing a letter do not differ significantly (p>0.05). Green lines at ≥75% knock-down = minimal 599 
effectiveness at 60 minutes and at ≥ 95% knock-down = optimal effectiveness at 60 minutes. 600 
Red lines at ≥50% mortality = minimal LLIN effectiveness at 24 hours and ≥80% mortality = 601 
optimal LLIN effectiveness at 24 hours, as defined by the WHO [21]. 602 
 603 
 604 
Figure 2. A: Resistance intensity of field-caught An. gambiae s.l. after exposure to one, two, 605 
five and ten times the diagnostic dose of pyrethroid insecticides.  Mean knock-down/acute 606 
toxicity after 30 minutes exposure with 95% confidence intervals (CI). Knock-down/mortality at 607 
the same dose per insecticide sharing a letter do not differ significantly (p>0.05). Values of less 608 
than 90% mortality (lower red line) indicate confirmed resistance at the diagnostic dose (1X) and 609 
values of less than 98% mortality (upper red line) indicate moderate to high intensity resistance 610 
or high intensity resistance at 5X and 10X, respectively, as defined by the WHO [24]. B: 611 
Restoration of deltamethrin susceptibility of field-caught An. gambiae s.l. after pre-exposure to 612 
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PBO. Mean knock-down/acute toxicity after 30 minutes exposure to one or two times the 613 
diagnostic dose of deltamethrin with 95% confidence intervals (CI). Knock-down/mortality 614 
between pyrethroid only and synergist + pyrethroid sharing a letter do not differ significantly 615 
(p>0.05). Red line at 98% mortality indicates metabolic resistance mechanisms partially 616 
involved [24]. 617 
 618 
 619 
620 
 621 
Figure 3. The longevity of field-caught An. gambiae s.l. after exposure to LLINs in WHO cone 622 
assays (A) 1X (B), 5X (C) and 10X (D) times the diagnostic dose of pyrethroid insecticides in 623 
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CDC resistance intensity assays. Kaplan Meier survival curves indicate the proportion alive 624 
each day post-exposure. Immediate mortality following LLIN (60 minutes and 24 hours) or 625 
insecticidal exposure (30 or 60 minutes, insecticide depending) were excluded.  626 
 627 
 628 
Figure 4. Metabolic gene expression in field An. coluzzii and An. gambiae s.s. populations 629 
relative to a susceptible colony population. Error bars represent 95% CI; statistically significant 630 
differences in expression levels relative to the susceptible colony are indicated as *P<0.05, 631 
**P<0.01, ***P≤0.001. 632 
 633 
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 634 
 635 
Figure 5. Metabolic gene expression in resistant versus susceptible field An. coluzzii, which 636 
either died or survived following insecticidal exposure. Error bars represent 95% CI.637 
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Table 1. Cox proportional hazard model to describe the impact of LLIN/insecticidal exposure 
on survival of field-caught An. gambiae s.l. 72 hours post exposure. 
Insecticide Exposure N (N Events) HRR 95% CI P-value 
Untreated Netting  Reference - - 
PermaNet® 2.0 (deltamethrin 
only) 
1135 (1047) 1.095 0.968-1.239 0.149 
PermaNet® 3.0 side panels 
(deltamethrin only) 
1157 (1088) 0.9664 0.9092-1.027 0.272 
PermaNet® 3.0 roof panels 
(PBO + deltamethrin) 
563 (533) 1.007 0.939-1.079 0.85 
Acetone Control  Reference - - 
Alpha-cypermethrin 1X 676 (641) 1.006 0.9696-1.043 0.767 
Deltamethrin 1X 683 (645) 0.9942 0.9539-1.036 0.782 
Permethrin 1X 693 (661) 1.015 0.9698-1.062 0.525 
Clothianidin 1X 698 (581) 1.208 0.9227-1.581 0.169 
Chlorfenapyr 1X 708 (580) 1.692 1.086-2.637 0.02 
PBO + Deltamethrin 1X 630 (577) 0.9662 0.2411-3.873 0.961 
Alpha-cypermethrin 5X 633 (601) 0.9951 0.9407-1.053 0.863 
Deltamethrin 5X 652 (610) 0.9942 0.9393-1.052 0.842 
Permethrin 5X 636 (583) 0.9931 0.8638-1.142 0.923 
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Alpha-cypermethrin 10X 624 (587) 0.9951 0.917-1.08 0.906 
Deltamethrin 10X 623 (588) 0.9943 0.9072-1.09 0.902 
Permethrin 10X 656 (603) 1.026 0.9509-1.107 0.509 
1X Insecticide Dose  Reference - - 
Alpha-cypermethrin 5X 117 (92) 1.016 0.9069-1.138 0.785 
Alpha-cypermethrin 10X 108 (78) 1.007 0.9403-1.078 0.845 
Deltamethrin 5X 143 (105) 1.0 0.9035-1.107 1.0 
Deltamethrin 10X 114 (83) 1.0 0.9363-1.068 1.0 
Permethrin 5X 137 (94) 1.022 0.8528-1.225 0.812 
Permethrin 10X 157 (114) 0.9952 0.9491-1.044 0.842 
HRR: hazard rate ratio; ratio between the hazard rate in control/reference group and hazard 
rate for each treatment group. 
Significance level defined as α = 0.05. 
Immediate mortality following LLIN (60 minutes and 24 hours) or insecticidal exposure (30 or 
60 minutes, insecticide depending) were excluded. 
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